Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ScreenASSIST: Tobacco Cessation in Lung Cancer Screening
NCT03611881Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2019
- Primary completion
- Jan 2024
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nicotine patch in Tobacco Use Disorder (TUD) (8 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Self-reported Past 7-day Smoking Abstinence at 6 months. Started Apr 2019; status: completed.
02
Drugs
nicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT03611881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03611881.